Coya Therapeutics Competitors and Similar CompaniesClear all
Coya Therapeutics's competitors and similar companies include Glyphic Biotechnologies, Genevant, AmacaThera and Monte Rosa Therapeutics.
 Coya Therapeutics Coya Therapeutics is a company that provides cell therapy platform developing treatments focused on the biology and potential therapeutic advantages of regulatory T cells (Tregs) to target systemic inflammation and neuroinflammation. |  Glyphic Biotechnologies Glyphic Biotechnologies is a biotechnology company that provides proteomics solutions. |  Genevant Genevant offers a lipid nanoparticle (LNP) platform that enables clinical development of RNA-based therapeutics. |  AmacaThera AmacaThera is a biotechnology company focused on developing and commercializing an injectable hydrogel platform technology for a wide range of medical applications. |  Monte Rosa Therapeutics Monte Rosa Therapeutics is a biopharmaceutical company that develops cancer therapeutics intended to modulate protein degradation pathways. | |
Founding Date | Founding Date 2020 | Founding Date 2021 | Founding Date 2017 | Founding Date 2016 | Founding Date 2018 |
Type | Type Public | Type Private | Type Private | Type Private | Type Public |
Tags | |||||
Locations | Locations Houston, US HQ | Locations Berkeley, US HQ | Locations New York, US HQ | Locations Toronto, CA HQ Toronto, CA | Locations Boston, US HQ Basel, CH Basel, CH Basel, CH Boston, US Cambridge, US |
Employees | Employees 6 | Employees 3310% increase | Employees 524% decrease | Employees 12 | Employees 75 |
Valuation ($) | Valuation ($) 170.5 m | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) 575.1 m |
Financial | |||||
Revenue (est.) | Revenue (est.) $7.9m (FY, 2025) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) $123.7m (FY, 2025) |
Net income | Net income ($21.2m) (FY, 2025) | Net income N/A | Net income N/A | Net income N/A | Net income ($38.6m) (FY, 2025) |
Funding | |||||
Latest funding round | Latest funding round N/A | Latest funding round $ 6m (almost 5 years ago) | Latest funding round N/A | Latest funding round $ 3.6m (over 6 years ago) | Latest funding round N/A |
Total funding raised | Total funding raised N/A | Total funding raised $ 6m | Total funding raised N/A | Total funding raised $ 6.1m | Total funding raised $ 223.5m |
For sources of this data, please see the company profile
View Company Profiles
Glyphic Biotechnologies
HQ
Berkeley, US
Employees
33↑ 10% increase
Glyphic Biotechnologies is a biotechnology company that provides proteomics solutions.
View companyGenevant
HQ
New York, US
Employees
52↓ 4% decrease
Genevant offers a lipid nanoparticle (LNP) platform that enables clinical development of RNA-based therapeutics.
View companyAmacaThera
HQ
Toronto, CA
Employees
12
AmacaThera is a biotechnology company focused on developing and commercializing an injectable hydrogel platform technology for a wide range of medical applications.
View companyMonte Rosa Therapeutics
HQ
Boston, US
Employees
75
Monte Rosa Therapeutics is a biopharmaceutical company that develops cancer therapeutics intended to modulate protein degradation pathways.
View company